Market Overview

Acceleron to Webcast Second Quarter 2018 Operating and Financial Results on August 2, 2018


Acceleron Pharma Inc. (NASDAQ:XLRN) today announced it will host a
webcast and conference call on Thursday, August 2, 2018 at 5:00 p.m. EDT
to discuss its second quarter 2018 operating and financial results.

The webcast will be accessible under "Events & Presentations" in the
Investors/Media page of the company's website at
Individuals can participate in the conference call by dialing
877-312-5848 (domestic) or 253-237-1155 (international)
and refer to the "Acceleron Second Quarter 2018 Earnings Call."

The archived webcast will be available for replay on the Acceleron
website approximately two hours after the event.

About Acceleron

Acceleron is a Cambridge-based, clinical-stage biopharmaceutical company
dedicated to the discovery, development, and commercialization of
therapeutics to treat serious and rare diseases. The Company's
leadership in the understanding of TGF-beta biology and protein
engineering generates innovative compounds that engage the body's
ability to regulate cellular growth and repair.

Acceleron focuses its research and development efforts in hematologic,
neuromuscular, and pulmonary diseases. In hematology, the Company and
its global collaboration partner, Celgene, are developing luspatercept
for the treatment of chronic anemia in myelodysplastic syndromes,
beta-thalassemia, and myelofibrosis. Acceleron is also advancing its
neuromuscular franchise with two distinct Myostatin+ agents, ACE-083 and
ACE-2494, and a pulmonary program with sotatercept in pulmonary arterial

For more information, please visit
Follow Acceleron on Social Media: @AcceleronPharma
and LinkedIn.

View Comments and Join the Discussion!